Genomic Health is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. The Oncotype DX® portfolio of tests provides physicians and patients with additional information about the molecular biology of a tumor to quantify risk and help guide treatment decisions.
If you are experiencing difficulty with activation or access to your online ordering account, please contact us at firstname.lastname@example.org with a description of the issue you are having.
Select the product you like to contact us about:
Oncotype DX Breast Recurrence Score
Oncotype DX Breast DCIS Score
Oncotype DX Colon Recurrence Score
Oncotype DX Genomic Prostate Score
Oncotype SEQ Liquid Select
The Oncotype DX Breast Cancer Assay can help physicians and patients decide on the best course of treatment. For invasive breast cancer, the Oncotype DX Breast Cancer Assay predicts chemotherapy benefits and the likelihood of distant breast cancer recurrence. Even when traditional measures seem conclusive, Oncotype DX Recurrence Score can lead to a different approach. Learn More